Last reviewed · How we verify

Morphine-Promethazine

Tel-Aviv Sourasky Medical Center · FDA-approved active Small molecule

Morphine provides opioid analgesia while promethazine enhances pain relief and reduces nausea through antihistamine and anticholinergic effects.

Morphine provides opioid analgesia while promethazine enhances pain relief and reduces nausea through antihistamine and anticholinergic effects. Used for Moderate to severe pain, Post-operative pain management.

At a glance

Generic nameMorphine-Promethazine
Also known asmorphine-phenergan
SponsorTel-Aviv Sourasky Medical Center
Drug classOpioid analgesic combination
TargetMu-opioid receptor (morphine); H1 histamine receptor (promethazine)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Morphine acts as a mu-opioid receptor agonist to reduce pain perception and emotional response to pain. Promethazine is a first-generation antihistamine and anticholinergic agent that potentiates opioid analgesia, reduces nausea and vomiting, and provides sedation, making it a common adjunct in opioid formulations for enhanced therapeutic effect.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results